Literature DB >> 25149528

The inflammasome in alcoholic hepatitis: Its relationship with Mallory-Denk body formation.

Yue Peng1, Barbara A French1, Brittany Tillman1, Timothy R Morgan2, Samuel W French3.   

Abstract

Recent studies indicate that the inflammasome activation plays important roles in the pathogenesis of alcoholic hepatitis (AH). Nod-like receptor protein 3 (NLRP3) is a key component of the macromolecular complex that is so called the inflammasome that triggers caspase 1-dependent maturation of the precursors of IL-1β and IL-18 cytokines. It is also known that the adaptor proteins including apoptosis-associated speck-like protein containing CARD (ASC) and the mitochondrial antiviral signaling protein (MAVS) are necessary for NLRP3-dependent inflammasome function. Steatohepatitis frequently includes Mallory-Denk body (MDB) formation. In the case of alcoholic steatohepatitis, MDB formation occurs in 80% of biopsies (French 1981; French 1981). While previous studies have focused on in vitro cell lines and mouse models, we are the first group to investigate inflammasome activation in AH liver biopsy specimen and correlate it with MDB formation. Expression of NOD1, NLRP3, ASC, NAIP, MAVS, caspase 1, IL-1β, IL-18, and other inflammatory components including IL-6, IL-10, TNF-α, IFN-γ, STAT3, and p65 was measured in three to eight formalin-fixed paraffin-embedded AH specimens and control normal liver specimens by immunofluorescence staining and quantified by immunofluorescence intensity. The specimens were double stained with ubiquitin to demonstrate the relationship between inflammasome activation and MDB formation. MAVS, caspase1, IL-18, and TNF-α showed increases in expression in AH compared to the controls (p<0.05), and NAIP expression markedly increased in AH compared to the controls (p<0.01). There was a trend that levels of NLRP3, ASC, caspase1, IL-18, IL-10, and p65 expression correlated with the number of MDBs found in the same field of measurement (correlation coefficients were between 0.62 and 0.93, p<0.05). Our results demonstrate the activation of the inflammasome in AH and suggest that MDB could be an indicator of the extent of inflammasome activation.
Copyright © 2014. Published by Elsevier Inc.

Entities:  

Keywords:  Alcoholic steatohepatitis; Inflammasome; Liver disease development; Mallory–Denk bodies (MDBs)

Mesh:

Substances:

Year:  2014        PMID: 25149528      PMCID: PMC4177273          DOI: 10.1016/j.yexmp.2014.08.006

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  26 in total

1.  Genetic background effects of keratin 8 and 18 in a DDC-induced hepatotoxicity and Mallory-Denk body formation mouse model.

Authors:  Johannes Haybaeck; Cornelia Stumptner; Andrea Thueringer; Thomas Kolbe; Thomas M Magin; Michael Hesse; Peter Fickert; Oleksiy Tsybrovskyy; Heimo Müller; Michael Trauner; Kurt Zatloukal; Helmut Denk
Journal:  Lab Invest       Date:  2012-03-26       Impact factor: 5.662

2.  Hepatocellular ballooning in NASH.

Authors:  Stephen Caldwell; Yoshihiro Ikura; Daniela Dias; Kosuke Isomoto; Akito Yabu; Christopher Moskaluk; Patcharin Pramoonjago; Winsor Simmons; Harriet Scruggs; Nicholas Rosenbaum; Timothy Wilkinson; Patsy Toms; Curtis K Argo; Abdullah M S Al-Osaimi; Jan A Redick
Journal:  J Hepatol       Date:  2010-06-25       Impact factor: 25.083

3.  Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells.

Authors:  Timea Csak; Michal Ganz; Justin Pespisa; Karen Kodys; Angela Dolganiuc; Gyongyi Szabo
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425

Review 4.  The Mallory body: structure, composition, and pathogenesis.

Authors:  S W French
Journal:  Hepatology       Date:  1981 Jan-Feb       Impact factor: 17.425

Review 5.  Inflammasomes in liver diseases.

Authors:  Gyongyi Szabo; Timea Csak
Journal:  J Hepatol       Date:  2012-05-23       Impact factor: 25.083

6.  Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome.

Authors:  Edward A Miao; Dat P Mao; Natalya Yudkovsky; Richard Bonneau; Cynthia G Lorang; Sarah E Warren; Irina A Leaf; Alan Aderem
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

7.  The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation.

Authors:  Naeha Subramanian; Kannan Natarajan; Menna R Clatworthy; Ze Wang; Ronald N Germain
Journal:  Cell       Date:  2013-04-11       Impact factor: 41.582

8.  TLR3/4 signaling is mediated via the NFκB-CXCR4/7 pathway in human alcoholic hepatitis and non-alcoholic steatohepatitis which formed Mallory-Denk bodies.

Authors:  Hui Liu; Jun Li; Brittany Tillman; Timothy R Morgan; Barbara A French; Samuel W French
Journal:  Exp Mol Pathol       Date:  2014-07-02       Impact factor: 3.362

9.  Ufmylation and FATylation pathways are downregulated in human alcoholic and nonalcoholic steatohepatitis, and mice fed DDC, where Mallory-Denk bodies (MDBs) form.

Authors:  H Liu; J Li; B Tillman; B A French; S W French
Journal:  Exp Mol Pathol       Date:  2014-06-02       Impact factor: 3.362

Review 10.  Emerging Concepts about NAIP/NLRC4 Inflammasomes.

Authors:  Silvia Lucena Lage; Carla Longo; Laura Migliari Branco; Thaís Boccia da Costa; Carina de Lima Buzzo; Karina Ramalho Bortoluci
Journal:  Front Immunol       Date:  2014-07-02       Impact factor: 7.561

View more
  18 in total

Review 1.  Target acquired: Selective autophagy in cardiometabolic disease.

Authors:  Trent D Evans; Ismail Sergin; Xiangyu Zhang; Babak Razani
Journal:  Sci Signal       Date:  2017-02-28       Impact factor: 8.192

Review 2.  A Unifying Hypothesis Linking Hepatic Adaptations for Ethanol Metabolism to the Proinflammatory and Profibrotic Events of Alcoholic Liver Disease.

Authors:  Zhi Zhong; John J Lemasters
Journal:  Alcohol Clin Exp Res       Date:  2018-09-17       Impact factor: 3.455

Review 3.  New insights into Nod-like receptors (NLRs) in liver diseases.

Authors:  Tao Xu; Yan Du; Xiu-Bin Fang; Hao Chen; Dan-Dan Zhou; Yang Wang; Lei Zhang
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2018-03-10

4.  NAIP expression increases in a rat model of liver mass restoration.

Authors:  Julio Plaza-Díaz; Ana I Álvarez-Mercado; Cándido Robles-Sánchez; Miguel Navarro-Oliveros; Virginia Morón-Calvente; Sofía Toribio-Castelló; María José Sáez-Lara; Alex MacKenzie; Luis Fontana; Francisco Abadía-Molina
Journal:  J Mol Histol       Date:  2020-11-25       Impact factor: 2.611

5.  Levels of metacaspase1 and chaperones related to protein quality control in alcoholic and nonalcoholic steatohepatitis.

Authors:  Alejandro S Mendoza; Jacques Dorce; Yue Peng; Barbara A French; Brittany Tillman; Jun Li; Samuel W French
Journal:  Exp Mol Pathol       Date:  2014-12-16       Impact factor: 3.362

Review 6.  Lytic cell death in metabolic liver disease.

Authors:  Jérémie Gautheron; Gregory J Gores; Cecília M P Rodrigues
Journal:  J Hepatol       Date:  2020-04-13       Impact factor: 25.083

Review 7.  The mechanisms of Mallory-Denk body formation are similar to the formation of aggresomes in Alzheimer's disease and other neurodegenerative disorders.

Authors:  S W French; A S Mendoza; Y Peng
Journal:  Exp Mol Pathol       Date:  2016-04-09       Impact factor: 3.362

Review 8.  Inflammasome activation and function in liver disease.

Authors:  Gyongyi Szabo; Jan Petrasek
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-06-09       Impact factor: 46.802

9.  Increased DNA methylation in the livers of patients with alcoholic hepatitis.

Authors:  Hong Shen; Barbara A French; Brittany C Tillman; Jun Li; Samuel W French
Journal:  Exp Mol Pathol       Date:  2015-08-08       Impact factor: 3.362

Review 10.  Inflammatory status in human hepatic cirrhosis.

Authors:  María Martínez-Esparza; María Tristán-Manzano; Antonio J Ruiz-Alcaraz; Pilar García-Peñarrubia
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.